OTC Pharmaceuticals in Canada

Date: September 27, 2016
Pages: 38
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O160ABD3C88EN
Leaflet:

Download PDF Leaflet

OTC Pharmaceuticals in Canada
SUMMARY

OTC Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Canada
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Canada
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Canada otc pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Canada otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Canada otc pharmaceuticals market by value in 2015?
  • What will be the size of the Canada otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Canada otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Canada's otc pharmaceuticals market?
KEY HIGHLIGHTS

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.

The Canadian OTC pharmaceuticals market generated total revenues of $2,717.1m in 2015, representing a compound annual growth rate (CAGR) of 2.9% between 2011 and 2015.

Cough and cold preparations recorded the highest sales value in the Canadian OTC pharmaceuticals market in 2015, with total sales of $619.4m, equivalent to 22.8% of the market's overall value.

A proliferation in availability of OTC drugs has helped to boost the Canadian market. The country is also benefitting from a variety of pharmaceutical tourism, with high drug costs and limited insurance plans in the US.
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
GlaxoSmithKline Plc
Johnson and Johnson
Pfizer Inc.
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Canada OTC pharmaceuticals market value: $ million, 2011-15
Table 2: Canada OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Canada OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Canada OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Canada OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: GlaxoSmithKline Plc: key facts
Table 8: GlaxoSmithKline Plc: key financials ($)
Table 9: GlaxoSmithKline Plc: key financials (£)
Table 10: GlaxoSmithKline Plc: key financial ratios
Table 11: Johnson and Johnson: key facts
Table 12: Johnson and Johnson: key financials ($)
Table 13: Johnson and Johnson: key financial ratios
Table 14: Pfizer Inc.: key facts
Table 15: Pfizer Inc.: key financials ($)
Table 16: Pfizer Inc.: key financial ratios
Table 17: Sanofi SA: key facts
Table 18: Sanofi SA: key financials ($)
Table 19: Sanofi SA: key financials (€)
Table 20: Sanofi SA: key financial ratios
Table 21: Canada size of population (million), 2011-15
Table 22: Canada gdp (constant 2005 prices, $ billion), 2011-15
Table 23: Canada gdp (current prices, $ billion), 2011-15
Table 24: Canada inflation, 2011-15
Table 25: Canada consumer price index (absolute), 2011-15
Table 26: Canada exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Canada OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: Canada OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Canada OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Canada OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Canada OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Canada, 2015
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Canada, 2015
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Canada, 2015
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Canada, 2015
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Canada, 2015
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Canada, 2015
Figure 13: GlaxoSmithKline Plc: revenues and profitability
Figure 14: GlaxoSmithKline Plc: assets and liabilities
Figure 15: Johnson and Johnson: revenues and profitability
Figure 16: Johnson and Johnson: assets and liabilities
Figure 17: Pfizer Inc.: revenues and profitability
Figure 18: Pfizer Inc.: assets and liabilities
Figure 19: Sanofi SA: revenues and profitability
Figure 20: Sanofi SA: assets and liabilities

COMPANIES MENTIONED

GlaxoSmithKline Plc
Johnson and Johnson
Pfizer Inc.
Sanofi SA
Skip to top


OTC Pharmaceuticals Global Industry Almanac_2016 US$ 2,995.00 Oct, 2016 · 491 pages
OTC Pharmaceuticals Global Industry Guide_2016 US$ 1,495.00 Oct, 2016 · 271 pages
Global OTC Pharmaceuticals US$ 350.00 Sep, 2016 · 38 pages

Ask Your Question

OTC Pharmaceuticals in Canada
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: